79 related articles for article (PubMed ID: 28429090)
21. Pancreaticoduodenectomy is justified in a subset of elderly patients with pancreatic ductal adenocarcinoma: A population-based retrospective cohort study of 4,283 patients.
Lu L; Zhang X; Tang G; Shang Y; Liu P; Wei Y; Gong P; Ma L
Int J Surg; 2018 May; 53():262-268. PubMed ID: 29604352
[TBL] [Abstract][Full Text] [Related]
22. Evolution and impact of lymph node dissection during pancreaticoduodenectomy for pancreatic cancer.
Eskander MF; de Geus SW; Kasumova GG; Ng SC; Al-Refaie W; Ayata G; Tseng JF
Surgery; 2017 Apr; 161(4):968-976. PubMed ID: 27865602
[TBL] [Abstract][Full Text] [Related]
23. Pancreatoduodenectomy associated complications influence cancer recurrence and time interval to death.
van der Gaag NA; Harmsen K; Eshuis WJ; Busch ORC; van Gulik TM; Gouma DJ
Eur J Surg Oncol; 2014 May; 40(5):551-558. PubMed ID: 24388408
[TBL] [Abstract][Full Text] [Related]
24. Effect of angiotensin 2 receptor blockers on chronic obstructive lung disease mortality: A retrospective cohort study.
Paulin P; Maritano Furcada J; Ungaro CM; Bendelman G; Waisman GD; Castro HM; Giunta DH; Ferreyro BL
Pulm Pharmacol Ther; 2017 Jun; 44():78-82. PubMed ID: 28315489
[TBL] [Abstract][Full Text] [Related]
25. Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry.
Song PS; Seol SH; Seo GW; Kim DK; Kim KH; Yang JH; Hahn JY; Gwon HC; Ahn Y; Jeong MH; Song YB; Kim DI;
Am J Cardiovasc Drugs; 2015 Dec; 15(6):439-49. PubMed ID: 26153396
[TBL] [Abstract][Full Text] [Related]
26. Low skeletal muscle mass outperforms the Charlson Comorbidity Index in risk prediction in patients undergoing pancreatic resections.
Wagner D; Marsoner K; Tomberger A; Haybaeck J; Haas J; Werkgartner G; Cerwenka H; Bacher H; Mischinger HJ; Kornprat P
Eur J Surg Oncol; 2018 May; 44(5):658-663. PubMed ID: 29428474
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers.
Opelz G; Döhler B
Transplantation; 2014 Feb; 97(3):310-5. PubMed ID: 24492421
[TBL] [Abstract][Full Text] [Related]
28. Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study.
Shen JI; Saxena AB; Vangala S; Dhaliwal SK; Winkelmayer WC
BMC Nephrol; 2017 Jun; 18(1):196. PubMed ID: 28623899
[TBL] [Abstract][Full Text] [Related]
29. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of vascular resection in pancreaticoduodenectomy: single-surgeon experience.
Menon VG; Puri VC; Annamalai AA; Tuli R; Nissen NN
Am Surg; 2013 Oct; 79(10):1064-7. PubMed ID: 24160800
[TBL] [Abstract][Full Text] [Related]
31. Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction.
Savarese G; Edner M; Dahlström U; Perrone-Filardi P; Hage C; Cosentino F; Lund LH
Int J Cardiol; 2015 Nov; 199():415-23. PubMed ID: 26247798
[TBL] [Abstract][Full Text] [Related]
32. Five-year actual survival after pancreatoduodenectomy for pancreatic head cancer.
Perysinakis I; Avlonitis S; Georgiadou D; Tsipras H; Margaris I
ANZ J Surg; 2015 Mar; 85(3):183-6. PubMed ID: 24165038
[TBL] [Abstract][Full Text] [Related]
33. Reappraisal of pancreatic adenocarcinoma undergoing pancreaticoduodenectomy.
Wang KC; Shyr YM; Wang SE; Su CH; Chen TH; Wu CW
Hepatogastroenterology; 2012 Sep; 59(118):1976-80. PubMed ID: 22819917
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage.
Eshuis WJ; van der Gaag NA; Rauws EA; van Eijck CH; Bruno MJ; Kuipers EJ; Coene PP; Kubben FJ; Gerritsen JJ; Greve JW; Gerhards MF; de Hingh IH; Klinkenbijl JH; Nio CY; de Castro SM; Busch OR; van Gulik TM; Bossuyt PM; Gouma DJ
Ann Surg; 2010 Nov; 252(5):840-9. PubMed ID: 21037440
[TBL] [Abstract][Full Text] [Related]
35. Beyond the dollar: Influence of sociodemographic marginalization on surgical resection, adjuvant therapy, and survival in patients with pancreatic cancer.
Kagedan DJ; Abraham L; Goyert N; Li Q; Paszat LF; Kiss A; Earle CC; Mittmann N; Coburn NG
Cancer; 2016 Oct; 122(20):3175-3182. PubMed ID: 27391466
[TBL] [Abstract][Full Text] [Related]
36. Socio-economic status influences the likelihood of undergoing surgical treatment for pancreatic cancer in the Netherlands.
Bakens MJAM; Lemmens VEPP; de Hingh IHJT
HPB (Oxford); 2017 May; 19(5):443-448. PubMed ID: 28223043
[TBL] [Abstract][Full Text] [Related]
37. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
[TBL] [Abstract][Full Text] [Related]
38. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
[TBL] [Abstract][Full Text] [Related]
39. Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis.
Alba MA; García-Martínez A; Prieto-González S; Espígol-Frigolé G; Butjosa M; Tavera-Bahillo I; Rodríguez-Pintó I; Hernández-Rodríguez J; Cid MC
Semin Arthritis Rheum; 2014 Jun; 43(6):772-7. PubMed ID: 24315461
[TBL] [Abstract][Full Text] [Related]
40. Portal vein resection in advanced pancreatic adenocarcinoma: is it worth the risk?
Marsoner K; Langeder R; Csengeri D; Sodeck G; Mischinger HJ; Kornprat P
Wien Klin Wochenschr; 2016 Aug; 128(15-16):566-72. PubMed ID: 27363995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
